Vitamins and breast cancer
Posted: Tue Oct 15, 2013 2:09 pmWomen with breast cancer a third less likely to die if they take multivitamins
14 October 2013
Women with breast cancer are more likely to survive if they take multivitamin and mineral supplements. They reduce the chances of dying from the cancer by around 30 per cent, researchers have found.
The supplements seem to have a protective effect in postmenopausal women whose breast cancer has become invasive—in other words, it had entered into the breast tissue.
Women who take multivitamin and mineral supplements at least once a week are 30 per cent less likely to die from the cancer than women who don’t take any supplements. Researchers from the Yeshiva University made the discovery when they analysed data from the Women’s Health Initiative (WHI), and the 7,728 women who were diagnosed with invasive breast cancer. Around 38 per cent of the women were taking a multivitamin, and most of these had been taking them before breast cancer had been detected.
(Source: Breast Cancer Research and Treatment, 2013; doi: 10.1007/s10549-013-2712-x)
- multivitamins 2.jpg (18.95 KiB) Viewed 7208 times
14 October 2013
Women with breast cancer are more likely to survive if they take multivitamin and mineral supplements. They reduce the chances of dying from the cancer by around 30 per cent, researchers have found.
The supplements seem to have a protective effect in postmenopausal women whose breast cancer has become invasive—in other words, it had entered into the breast tissue.
Women who take multivitamin and mineral supplements at least once a week are 30 per cent less likely to die from the cancer than women who don’t take any supplements. Researchers from the Yeshiva University made the discovery when they analysed data from the Women’s Health Initiative (WHI), and the 7,728 women who were diagnosed with invasive breast cancer. Around 38 per cent of the women were taking a multivitamin, and most of these had been taking them before breast cancer had been detected.
(Source: Breast Cancer Research and Treatment, 2013; doi: 10.1007/s10549-013-2712-x)